URIST MARSHALL (EVP & Co-Head Research & Inv.) sold 9.10K shares of ROYALTY PHARMA PLC on the open market
Open‑market sale worth $508.5K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/2/2026ACC: 0001838139-26-000022
Officer· EVP & Co-Head Research & Inv.
Since Dec 2020
-9.10K
Net shares
Net seller
$508.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
9.10K disposed
Non-Derivative Transactions1
Class A Ordinary Shares
Direct
Shares
−9.10K
Price / share
$55.88
Trade value
$508.45K
% of position
New position
7/1/2026
9.10K→0.00
Total
Net shares
−9.10K
Net value
-$508.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Shares Direct | 7/1/2026 | S · Sale | −9.10K | $55.88 | $508.45K | New position | 9.10K | 0.00 |
| Total | −9.10K | -$508.45K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A Ordinary Shares
IndirectShares owned19.02K
Total
19.02K indirect19.02K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Ordinary Shares | 19.02K | Indirect |
| Total | 19.02K | 19.02K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported